The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy
Authors
Keywords
-
Journal
PLoS One
Volume 18, Issue 2, Pages e0281375
Publisher
Public Library of Science (PLoS)
Online
2023-02-07
DOI
10.1371/journal.pone.0281375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
- (2021) Françoise Gondois-Rey et al. Cancers
- Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
- (2020) Anders Etzerodt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
- (2019) Leticia De Mattos-Arruda et al. Cell Reports
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
- (2019) Shixiang Wang et al. eLife
- Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
- (2019) Si Yang et al. OncoImmunology
- Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
- (2018) Kyle Ellrott et al. Cell Systems
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- Gene expression markers of Tumor Infiltrating Leukocytes
- (2017) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Near-optimal probabilistic RNA-seq quantification
- (2016) Nicolas L Bray et al. NATURE BIOTECHNOLOGY
- Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias
- (2016) Andrew Dunford et al. NATURE GENETICS
- Metastasis as an evolutionary process
- (2016) S. Turajlic et al. SCIENCE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer
- (2016) Jae-Young Park et al. Clinics and Research in Hepatology and Gastroenterology
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
- (2014) Sandra S. McAllister et al. NATURE CELL BIOLOGY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
- (2013) Arjen Joosse et al. JOURNAL OF CLINICAL ONCOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Enigmatic sex disparities in cancer incidence
- (2012) Gustaf Edgren et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Innate immunity
- (2009) Stuart E. Turvey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now